Poliomyelitis (commonly called polio or infantile paralysis) is an infectious disease caused by polioviruses, a group of three serotypes of enterovirus RNA viruses that primarily infect the human gastrointestinal tract and sometimes the central nervous system, leading to paralysis. Despite global vaccination efforts, poliovirus remains a threat in certain regions, necessitating reliable diagnostic methods for infection and immunity assessment.
The Poliomyelitis Virus ELISA Kit is a precise immunoassay designed for the in vitro quantitative and qualitative measurement of human IgG antibodies directed against poliovirus types 1, 2, and 3 in serum or plasma samples. This kit targets the detection of antibodies indicative of past infection, vaccination, or immunity status, facilitating epidemiological surveillance and clinical diagnosis.
Applications
- Detection and quantification of anti-polio IgG antibodies in vaccinated individuals or suspected past infection cases.
- Epidemiological studies for monitoring population immunity levels.
- Supporting poliovirus eradication programs by identification of susceptible populations.
- Research use in vaccine development and immunological studies.
The Poliomyelitis Virus ELISA Kit provides a robust, sensitive, and specific method for detecting human anti-polio IgG antibodies. It supports clinical diagnostics, immunization monitoring, and polio eradication efforts by enabling accurate serological assessment of poliovirus exposure and immunity.